4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-24-000114
Director sold 5,241 shares at $8.43 ($44,182)
- Director acquired 17,913 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Smith Karen L. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-08 | Exercise or conversion : show line 1 in the form | +17,913 | 17,913 | D | ||
| 2024-11-11 | Sale : show line 2 in the form | −5,241 | $8.43 | $44,182 | 12,672 | D |
| Open-market sales · 5,241 sh · avg $8.43 · $44,182 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-08 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −17,913 | 0 | D |
Loading xslF345X05/wk-form4_1731457229.xml…